News

Announcement regarding coronavirus and the precautions taken at the Institute of Neurogenetics

Dear members of the Institute of Neurogenetics and dear visitors of our website, During the Covid-19 pandemic, laboratory research activities at the Institute of Neurogenetics are focusing on critical experiments mandatory for the maintenance of the Drosophila and induced pluripotent stem cell (iPSC) resources. Other regular research activities are being carried out in Home office …

Announcement regarding coronavirus and the precautions taken at the Institute of Neurogenetics Read More »

International recognition for Prof. Dr. Christine Klein

Prof. Dr. Christine Klein, Director of the Institute of Neurogenetics at the University of Lübeck and the University Hospital Schleswig-Holstein (UKSH), has received three international awards for her research on movement disorders. She was awarded the “C. David Marsden Lecture Award” of the International Parkinson and Movement Disorder Society, which is presented once a year. …

International recognition for Prof. Dr. Christine Klein Read More »

Dr. Prasuhn awarded with a Junior award from the German Parkinson Foundation

On September 26th, Dr Jannik Prasuhn from the Institute of Neurogenetics and the Department of Neurology received a Junior award from the German Parkinson Foundation (25.000 Euro). He will be supported for his project entitled “Broadband near-infrared spectroscopy for the identification of mitochondrial endophenotypes in Parkinson’s disease”. Congratulations!

Anne Weißbach awarded with the David Marsden Award 2019

Dr. med. Anne Weißbach from the Institute of Neurogenetics at the University of Lübeck was awarded the David Marsden Award 2019 for her research. The Dystonia Europe Prize, which has been awarded every two years since 2003, is named after David Marsden (1938-1998), one of the leading European neurologists of his time. The Marsden Award …

Anne Weißbach awarded with the David Marsden Award 2019 Read More »

Modifier of disease severity and cognitive dysfunction in X-linked dystonia-parkinsonism identified

Members of the Institute of Neurogenetics in collaboration with other members of the “ProtectMove” Consortium (funded by the German Research Foundation, DFG FOR2488) have recently identified a novel modifier of disease severity and cognitive dysfunction in X-linked dystonia-parkinsonism. This study was published in Annals of Neurology, one of the five leading “Clinical Neurology” journals in …

Modifier of disease severity and cognitive dysfunction in X-linked dystonia-parkinsonism identified Read More »